본문 바로가기
KERD
논문KCI 등재

Hypoxia-hindered methylation of PTGIS in endometrial stromal cells accelerates endometriosis progression by inducing CD16− NK-cell differentiation

0

조회

0

다운로드

1

인용

0

참고문헌

주제분류생화학

초록

Prostacyclin (PGI2) plays key roles in shaping the immune microenvironment and modulating vasodilation, whereas its contribution to endometriosis (EMs) remains largely unclear. Our study suggested that prostacyclin synthase (PTGIS)-dependent PGI2 signaling was significantly activated in EMs, which was involved in the hypoxic microenvironment of ectopic lesions and deficient methylation status of the PTGIS promoter. Notably, in vitro assays, hypoxia promoted PTGIS expression through DNA methyltransferase 1 (DNMT1)-mediated DNA methylation deficiency in endometrial stromal cells (ESCs); PTGIS overexpression enhanced the adhesive ability of ESCs and led to elevated PGI2 production, and PGI2 triggered CD16− (encoded by FCGR3, Fc fragment of IgG receptor IIIa) natural killer (NK)-cell differentiation through PGI2 receptor (IP, PTGIR) in an ESC/NK-cell coculture system. Our rodent model experiment suggested that treatment with the PGI2 analog iloprost and adoptive transfer of fcgr3 knockout (fcgr3−/−) NK cells aggravated EMs progression and that genetic ablation of ptgis (ptgis−/−) in ectopic lesions and treatment with the PTGIR antagonist RO1138452 partially rescued this outcome. Thus, our findings identified the contribution of PGI2 to EMs progression via enhancement of the adhesive ability of ESCs and inhibition of the activity of NK cells. We hypothesized that PGI2 is a target for EMs intervention and provide a rationale for studying pharmacological PTGIR inhibition and PTGIS genetic depletion therapies as therapeutic strategies for EMs.

Abstract

Prostacyclin (PGI2) plays key roles in shaping the immune microenvironment and modulating vasodilation, whereas its contribution to endometriosis (EMs) remains largely unclear. Our study suggested that prostacyclin synthase (PTGIS)-dependent PGI2 signaling was significantly activated in EMs, which was involved in the hypoxic microenvironment of ectopic lesions and deficient methylation status of the PTGIS promoter. Notably, in vitro assays, hypoxia promoted PTGIS expression through DNA methyltransferase 1 (DNMT1)-mediated DNA methylation deficiency in endometrial stromal cells (ESCs); PTGIS overexpression enhanced the adhesive ability of ESCs and led to elevated PGI2 production, and PGI2 triggered CD16− (encoded by FCGR3, Fc fragment of IgG receptor IIIa) natural killer (NK)-cell differentiation through PGI2 receptor (IP, PTGIR) in an ESC/NK-cell coculture system. Our rodent model experiment suggested that treatment with the PGI2 analog iloprost and adoptive transfer of fcgr3 knockout (fcgr3−/−) NK cells aggravated EMs progression and that genetic ablation of ptgis (ptgis−/−) in ectopic lesions and treatment with the PTGIR antagonist RO1138452 partially rescued this outcome. Thus, our findings identified the contribution of PGI2 to EMs progression via enhancement of the adhesive ability of ESCs and inhibition of the activity of NK cells. We hypothesized that PGI2 is a target for EMs intervention and provide a rationale for studying pharmacological PTGIR inhibition and PTGIS genetic depletion therapies as therapeutic strategies for EMs.

참고문헌 (54)

  1. Bulun, S. E., "Endometriosis", Endocr. Rev, 40, pp.1048~1079 (2019)
  2. Zondervan, K. T., "Endometriosis", N. Engl. J. Med, 382, pp.1244~1256 (2020)
  3. Peiris, A. N., "Endometriosis", JAMA, 320, pp.2608~ (2018)
  4. Koninckx, P. R., "Pathogenesis of endometriosis: the genetic", epigenetic theory, 2019, pp.111, 327~340
  5. Zhang, T., "The link between immunity, autoimmunity and endometriosis: a literature update", Autoimmun. Rev, 17, pp.945~955 (2018)
  6. Vallvé-Juanico, J., "The endometrial immune environment of women with endometriosis", Hum. Reprod. Update, 25, pp.564~591 (2019)
  7. Jeljeli, M., "Macrophage immune memory controls endometriosis in mice and humans", Cell Rep, 33, pp.108325~ (2020)
  8. Alvarado-Díaz, C. P., "Iron overloadmodulated nuclear factor kappa-B activation in human endometrial stromal cells as a mechanism postulated in endometriosis pathogenesis", Fertil. Steril, 103, pp.439~447 (2015)
  9. Rudzitis-Auth, J., "Inhibition of cyclooxygenase-2 suppresses the recruitment of endothelial progenitor cells in the microvasculature of endometriotic lesions", Am. J. Pathol, 188, pp.450~460 (2018)
  10. Yamanaka, K., "Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic stromal cells in spheroid culture", Fertil. Steril, 97, pp.477~482 (2012)
  11. Fagotti, A., "Analysis of cyclooxygenase-2(COX-2)expression in different sites of endometriosis and correlation with clinico-pathological parameters", Hum. Reprod, 19, pp.393~397 (2004)
  12. McLaughlin, V. V., "Results of an expert consensus survey on the treatment of pulmonary arterial hypertension with oral prostacyclin pathway agents", Chest, 157, pp.955~965 (2020)
  13. Carvalho, J., "Orphan G protein-coupled receptor GPRC5B controls smooth muscle contractility and differentiation by inhibiting prostacyclin receptor signaling", Circulation, 141, pp.1168~1183 (2020)
  14. Waxman, A. B., "Oral prostacyclin therapy for pulmonary arterial hypertension : another step forward", Circulation, 127, pp.563~565 (2013)
  15. Pluchart, H., "Targeting the prostacyclin pathway : beyond pulmonary arterial hypertension", Trends Pharmacol. Sci, 38, pp.512~523 (2017)
  16. Hutchison, M. R., "Prostacyclin regulates bone growth via the Epac", Rap1 pathway, 2015, pp.156, 499~510
  17. Tamosiuniene, R., "Dominant role for regulatory T cells in protecting females against pulmonary hypertension", Circ. Res, 122, pp.1689~1702 (2018)
  18. Peshavariya, H. M., "Prostacyclin signaling boosts NADPH oxidase 4 in the endothelium promoting cytoprotection and angiogenesis", Antioxid. Redox Signal, 20, pp.2710~2725 (2014)
  19. Simons, B., "PGI2 controls pulmonary NK cells that prevent airway sensitization to house dust mite allergen", J. Immunol, 198, pp.461~471 (2017)
  20. Boswell, M. G., "PGI2 as a regulator of CD4+ subset differentiation and function", Prostaglandins Other Lipid Mediat, 96, pp.21~26 (2011)
  21. Toki, S., "PGI2 signaling inhibits antigen uptake and increases migration of immature dendritic cells", J. Leukoc. Biol, 94, pp.77~88 (2013)
  22. Wendler, S., "Immune modulation to enhance bone healing-a new concept to induce bone using prostacyclin to locally modulate immunity", Front. Immunol, 10, pp.713~ (2019)
  23. Zhou, W., "Prostaglandin I2 suppresses proinflammatory chemokine expression, CD4 T cell activation, and STAT6-independent allergic lung inflammation", J. Immunol, 197, pp.1577~1586 (2016)
  24. Zhou, W., "The PGI2 analog cicaprost inhibits IL-33-induced Th2 responses, IL-2 production, and CD25 expression in mouse CD4+ T cells", J. Immunol, 201, pp.1936~1945 (2018)
  25. Kim, J., "Human follicular dendritic cells promote germinal center B cell survival by providing prostaglandins", Mol. Immunol, 55, pp.418~423 (2013)
  26. Drake, T. S., "Peritoneal fluid thromboxane B2 and 6-keto-prostaglandin F1 alpha in endometriosis", Am. J. Obstet. Gynecol, 140, pp.401~404 (1981)
  27. Carrega, P., "Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells", Cancer, 112, pp.863~875 (2008)
  28. Gogali, F., "CD3(-)CD16(-)CD56(bright)immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer", Thyroid, 23, pp.1561~1568 (2013)
  29. Harlin, H., "The CD16-CD56(bright)NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim)subset", J. Immunol, 179, pp.4513~4519 (2007)
  30. Mamessier, E., "Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsets", J. Immunol, 190, pp.2424~2436 (2013)
  31. Mei, J., "Suppression of autophagy and HCK signaling promotes PTGS2high FCGR3-NK cell differentiation triggered by ectopic endometrial stromal cells", Autophagy, 14, pp.1376~1397 (2018)
  32. Hsiao, K. Y., "Inhibition of dual specificity phosphatase-2 by hypoxia promotes interleukin-8-mediated angiogenesis in endometriosis", Hum. Reprod, 29, pp.2747~2755 (2014)
  33. Li, W. N., "HYPOXIA AND REPRODUCTIVE HEALTH : The role of hypoxia in the development and progression of endometriosis", Reproduction, 161, pp.F19~F31 (2021)
  34. Xiong, Y., "Hypoxia-inducible factor 1α-induced epithelial-mesenchymal transition of endometrial epithelial cells may contribute to the development of endometriosis", Hum. Reprod, 31, pp.1327~1338 (2016)
  35. Pan, X. Y., "DNA Methylation of PTGIS Enhances Hepatic Stellate Cells Activation and Liver Fibrogenesis", Front. Pharmacol, 9, pp.553~ (2018)
  36. Frigola, J., "Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidy", Oncogene, 24, pp.7320~7326 (2005)
  37. Lu, M., "CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1α", Cell Death Dis, 9, pp.1046~ (2018)
  38. Hsiao, K. Y., "Coordination of AUF1 and miR-148a destabilizes DNA methyltransferase 1 mRNA under hypoxia in endometriosis", Mol. Hum. Reprod, 21, pp.894~904 (2015)
  39. Ota, H., "Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis", Hum. Reprod, 16, pp.561~566 (2001)
  40. Hirata, T., "Interleukin-17F increases the secretion of interleukin-8 and the expression of cyclooxygenase 2 in endometriosis", Fertil. Steril, 96, pp.113~117 (2011)
  41. Wang, X. J., "Association of rare PTGIS variants with susceptibility and pulmonary vascular response in patients with idiopathic pulmonary arterial hypertension", JAMA Cardiol, 5, pp.677~684 (2020)
  42. Bai, Y. P., "Induction of microRNA-199 by nitric oxide in endothelial cells is required for nitrovasodilator resistance via targeting of prostaglandin I2 synthase", Circulation, 138, pp.397~411 (2018)
  43. Pan, X. Y., "Alternative activation of macrophages by prostacyclin synthase ameliorates alcohol induced liver injury", Lab. Invest, 101, pp.1210~1224 (2021)
  44. Kitajima, S., "Hypoxia-inducible factor-2 alpha up-regulates CD70 under hypoxia and enhances anchorage-independent growth and aggressiveness in cancer cells", Oncotarget, 9, pp.19123~19135 (2018)
  45. Gao, X., "Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 protein", PLoS. One, 12, pp.e0171616~ (2017)
  46. Xu, R., "Hypoxic preconditioning inhibits hypoxiainduced apoptosis of cardiac progenitor cells via the PI3K", Akt-DNMT1-p53Pathway, 2016, pp.6, 30922~
  47. Xu, X. H., "Hypoxic-stabilized EPAS1 proteins transactivate DNMT1 and cause promoter hypermethylation and transcription inhibition of EPAS1 in non-small cell lung cancer", FASEB J, 32, pp.6694~6705 (2018)
  48. Murray, J., "Reduced prostaglandin I2 signaling in Arid5b-", -primary skeletal muscle cells attenuates myogenesis, 2018, pp.32, 1868~1879
  49. Ghandour, R. A., "IP-receptor and PPARs trigger the conversion of human white to brite adipocyte induced by carbaprostacyclin", Biochim. Biophys. Acta, 1861, pp.285~293 (2016)
  50. Cebola, I., "Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer", Clin. Epigenetics, 7, pp.74~ (2015)
  51. Sun, L. C., "Overexpression of PTGIS could predict liver metastasis and is correlated with poor prognosis in colon cancer patients", Pathol. Oncol. Res, 18, pp.563~569 (2012)
  52. Bai, K. H., "Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index", Cancer Med, 9, pp.4290~4298 (2020)
  53. Marotta, L. L., "The JAK2", STAT3 signaling pathway is required for growth of CD44+CD24-stem cell-like breast cancer cells in human tumors, 2011, pp.121, 2723~2735
  54. Yan, S., "I prostanoid receptor-mediated inflammatory pathway promotes hepatic gluconeogenesis through activation of PKA and inhibition of AKT", Diabetes, 63, pp.2911~2923 (2014)

관련 논문AI추천

IL-17A and Th17 Cells Contribute to Endometrial Cell Survival by Inhibiting Apoptosis and NK Cell Mediated Cytotoxicity of Endometrial Cells via ERK1/2 Pathway정인철, Cho Hee Jun, Choi Inpyo, Jung Haiyoung, Jung Yong-Wook, Kang Young-Ju, Kim Mi Jeong, Lee Hee Gu, Lee Yunhee, Park Arum, Yoon Suk Ran대한면역학회 · Immune Network2023 · 제23권 제2호Cytokines, Angiogenesis, and Extracellular Matrix Degradation are Augmented by Oxidative Stress in EndometriosisAmalesh Nanda, Koel Chaudhury, Mainak Dutta, Pramod Sharma, Priyanka Banerjee, Saikat Kumar Jana, Thangapandi K., Tsering Wangdi대한진단검사의학회 · Annals of Laboratory Medicine2020 · 제40권 제5호Gene Expression Profiling and Pathway Analysis of the Effect of Dienogest on Ovarian Endometriosis: A Comparative Study김희연, 백진경, 서석교, 심정은, 윤보현, 정윤수, 최은아연세대학교의과대학 · Yonsei Medical Journal2025 · 제66권 제11호EXPRESSION OF MEMBRANE TYPE-2 AND -3 MATRIX METALLOPROTEINASES IN EUTOPIC ENDOMETRIUM OF WOMEN WITH ADVANCED ENDOMETRIOSIS이지영, 정경아, 정현경, 정혜원대한산부인과학회 · Obstetrics & Gynecology Science2011 · 제54권 제08호Increased expression of nuclear factor kappa-B p65 subunit in adenomyosis강병문, 김성훈, 김정훈, 박하나, 오영상, 임효진, 조유미, 채희동, 홍승화대한산부인과학회 · Obstetrics & Gynecology Science2016 · 제59권 제2호Chitinase-3-like protein 1, matrix metalloproteinase-9, and monocyte chemoattractant protein-1 as potential biomarkers and treatment targets of adenomyosisAlvin Setiawan, Dian Tjahyadi, Hanom Husni Syam, Putu Doster Mahayasa, Ruswana Anwar, Tita Husnitawati Madjid, Wiryawan Permadi대한산부인과학회 · Obstetrics & Gynecology Science2024 · 제67권 제4호

이 간행물의 다른 논문 (191건)